The Food and Drug Administration (FDA) is investigating “possible alternative approaches” to regulating CBD products, Commissioner Scott Gottlieb said on Tuesday. During a speech at a conference hosted by the National Association of State Departments of Agriculture, Gottlieb recognized that many members of the organization were interested in the “regulatory framework for products derived from … Continue reading FDA Is Exploring ‘Alternative Approaches’ To CBD Regulation, Commissioner Says